Status:

RECRUITING

Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study

Lead Sponsor:

M.D. Anderson Cancer Center

Conditions:

Peripheral Nerve Stimulation

Chemotherapy-induced Peripheral Neuropathy

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

To learn if peripheral nerve stimulation (PNS) can help to improve pain in participants with CIPN.

Detailed Description

Primary objective: To assess Pain intensity (NRS) scores in chemotherapy induced peripheral neuropathy (CIPN) participants before and after use of peripheral nerve stimulation (PNS). Secondary objec...

Eligibility Criteria

Inclusion

  • Participants diagnosed with chronic (≥90 days duration) CIPN (due to either vinca alkaloids, taxanes, bortezomib, thalidomide, platinum-based compounds or ionizing irradiation) of the lower extremity, seen at Pain Management Center at MD Anderson Cancer Center
  • Participants reports baseline pain ≥ 4 (0-10 scale, NRS)
  • Participants between ages 18-85 years old
  • Participants who have completed chemotherapy within the previous year at the time of enrollment

Exclusion

  • Participants with cognitive dysfunction
  • Participants with recent history (\<6 months) of drug or alcohol abuse
  • Participants with open skin lesion or undergoing antibiotic therapy for local for systemic infection
  • Participants with allergies to local anesthesia, steroids, or adhesives
  • Participants with conditions that conflict with the SPRINT PNS System Indications for Use, including Contraindications and Warnings.

Key Trial Info

Start Date :

February 22 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT06162403

Start Date

February 22 2024

End Date

December 31 2027

Last Update

August 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

MD Anderson Cancer Center

Houston, Texas, United States, 77030